1. Home
  2. MCHB vs EWTX Comparison

MCHB vs EWTX Comparison

Compare MCHB & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MCHB

Mechanics Bancorp

HOLD

Current Price

$15.64

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$44.87

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCHB
EWTX
Founded
1905
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MCHB
EWTX
Price
$15.64
$44.87
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$15.75
$39.00
AVG Volume (30 Days)
483.2K
1.5M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
5.53%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$43.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.82
$12.31
52 Week High
$16.53
$43.93

Technical Indicators

Market Signals
Indicator
MCHB
EWTX
Relative Strength Index (RSI) 53.63 70.15
Support Level $13.90 $28.27
Resistance Level $15.71 N/A
Average True Range (ATR) 0.39 2.42
MACD 0.03 0.42
Stochastic Oscillator 57.70 92.85

Price Performance

Historical Comparison
MCHB
EWTX

About MCHB Mechanics Bancorp

Mechanics Bancorp is an independent, full-service community bank. It provides personal banking, business banking, trust and estate, brokerage and wealth management services. its retail banking products include personal checking, savings, and loan products (including credit card, home equity, home mortgage, and secured/unsecured loans), online banking, and wealth management services (including trust and estate, investment management, and financial planning services). its banking products and services for businesses include business checking and savings accounts, business debit cards, online banking, cash management services, wealth management services, business credit cards, commercial real estate loans, equipment leasing, and loans guaranteed by the Small Business Administration.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: